Axone Pharma SA
28.2 FTEAxone Pharma reported revenue of €27.1m for the 2025 financial year (annual accounts filed with the NBB on 05 Jun 2026), with 28.2 full-time equivalents.
The score of Axone Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +96 % Equity -7 % Total assets +60 % Headcount (avg FTE) -8 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Axone Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €27.1m | ||||
| Net result | €1.61m | ||||
| Equity | €8.08m | ||||
| Cash | €2.75m | ||||
| EBITDA | €2.44m | ||||
| Total assets | €16.2m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Jun 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Axone Pharma's financial analysis
- Solvency49.8%sector median: 41.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Axone Pharma
Axone Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0830.551.216
- VAT number
- BE0830551216
- Peppol
- Registered · 0208:0830551216 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 22 Oct 2010
- Registered office
- 1420 Braine-l'Alleud
- Size
- Small · 28.2 FTE
- Latest accounts
- 2025 · filed on 05 Jun 2026
- Activity
- Activities of agents involved in the wholesale of other particular products (NACE 46180)
Axone Pharma (SA) has been based in Braine-l'Alleud since 2010, active in: activities of agents involved in the wholesale of other particular products. For 2025, it reports revenue of €27.1m, a net profit of €1.61m and equity of €8.08m. With 28.2 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 49.8%, above the median of its sector (41.0%).
Companies similar to Axone Pharma
Companies in the same business, of comparable size and area, outside its group.
- Exphar Wholesale of pharmaceutical and medical goods Nivelles · balance sheet €14.1m
- Departement Central DE Fractionnement Manufacture of pharmaceutical preparations Brussels · balance sheet €19.7m
- Inteliphage Manufacture of basic pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet €12.6m
- Antwerps Distributie Centrum Wholesale of pharmaceutical and medical goods Kontich · balance sheet €15.4m
- ixX pharma Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €11.3m
- Recordati Wholesale of pharmaceutical and medical goods Jette · balance sheet €20.8m
- Infinity Pharma Wholesale of pharmaceutical and medical goods Nazareth-De Pinte · balance sheet €18.8m
- Euro - Medic Wholesale of pharmaceutical and medical goods Deinze · balance sheet €14.1m
Frequently asked questions about Axone Pharma
What is the revenue of Axone Pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of Axone Pharma amounts to 27,080,922 €.
What is the VAT number of Axone Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0830551216 for Axone Pharma, if the company is VAT-registered. Its company number (CBE) is 0830.551.216.
Where is the registered office of Axone Pharma?
According to the CBE register, the registered office of Axone Pharma is in 1420 Braine-l'Alleud.
What is the equity of Axone Pharma?
At the close of the 2025 financial year, the equity of Axone Pharma amounts to 8,077,783 €, a solvency of 49.8% of total assets.
How many people work at Axone Pharma?
28.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Axone Pharma?
The register lists 7 active mandates at Axone Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Axone Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →